We evaluated plasma levels of soluble VEGFR1 in patients with bisphosphonate-associated osteonecrosis of the jaw. Although zoledronic acid is able to induce a significant decrease in VEGF, we have not demonstrated a functional role for sVEGFR1 in ONJ patients.
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1
NASTRO SINISCALCHI, Enrico;
2007-01-01
Abstract
We evaluated plasma levels of soluble VEGFR1 in patients with bisphosphonate-associated osteonecrosis of the jaw. Although zoledronic acid is able to induce a significant decrease in VEGF, we have not demonstrated a functional role for sVEGFR1 in ONJ patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
